FUJIFILM India supports AIIMS for study on AI assisted early detection of upper gastrointestinal cancers

FUJIFILM India has announced its support through its Corporate Social Responsibility (CSR) initiative, for a landmark clinical research study led by the All India Institute of Medical Sciences (AIIMS), New Delhi.

The study aims to evaluate the effectiveness of artificial intelligence (AI)-assisted endoscopy in improving the early detection of upper gastrointestinal (UGI) malignancies, an area where timely diagnosis remains critical to improving patient outcomes. Upper gastrointestinal cancers continue to contribute significantly to cancer-related morbidity and mortality in India.

While early detection can substantially improve survival outcomes, many early-stage lesions remain difficult to identify during routine examinations owing to their subtle appearance and variability in detection. Emerging evidence indicates that AI-assisted endoscopy has the potential to enhance real-time lesion detection by supporting clinicians in identifying abnormalities that may otherwise be overlooked.

This collaborative research seeks to generate robust clinical evidence in the Indian healthcare setting and contribute to the advancement of evidence-based endoscopic practices. 

The collaboration also reflects FUJIFILM India's broader vision of advancing the endoscopy ecosystem in India through technology, clinical research and long-term healthcare partnerships. By supporting evidence generation alongside innovation, the company continues to contribute towards strengthening diagnostic capabilities and enabling more informed clinical decision-making across the healthcare ecosystem.